» Articles » PMID: 26493631

Caffeine Stimulates Locomotor Activity in the Mammalian Spinal Cord Via Adenosine A1 Receptor-dopamine D1 Receptor Interaction and PKA-dependent Mechanisms

Overview
Specialties Neurology
Pharmacology
Date 2015 Oct 24
PMID 26493631
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Caffeine is a potent psychostimulant that can have significant and widely variable effects on the activity of multiple neuronal pathways. The most pronounced caffeine-induced behavioral effect seen in rodents is to increase locomotor activity which has been linked to a dose-dependent inhibition of A1 and A(2A) receptors. The effects of caffeine at the level of the lumbar spinal central pattern generator (CPG) network for hindlimb locomotion are lacking. We assessed the effects of caffeine to the locomotor function of the spinal CPG network via extracellular ventral root recordings using the isolated neonatal mouse spinal cord preparation. Addition of caffeine and of an A1 receptor antagonist significantly decreased the cycle period accelerating the ongoing locomotor rhythm, while decreasing burst duration reversibly in most preparations suggesting the role of A1 receptors as the primary target of caffeine. Caffeine and an A1 receptor antagonist failed to stimulate ongoing locomotor activity in the absence of dopamine or in the presence of a D1 receptor antagonist supporting A1/D1 receptor-dependent mechanism of action. The use of caffeine or an A1 receptor blocker failed to stimulate an ongoing locomotor rhythm in the presence of a blocker of the cAMP-dependent protein kinase (PKA) supporting the need of this intracellular pathway for the modulatory effects of caffeine to occur. These results support a stimulant effect of caffeine on the lumbar spinal network controlling hindlimb locomotion through the inhibition of A1 receptors and subsequent activation of D1 receptors via a PKA-dependent intracellular mechanism.

Citing Articles

The association of gene polymorphisms of adenosine and dopamine receptors with the response to caffeine citrate treatment in infants with apnea of prematurity: a prospective nested case-control study.

Xie J, Zhuang W, Zhu Y, Zheng Z, Huang Y, Ma S Ital J Pediatr. 2024; 50(1):225.

PMID: 39468580 PMC: 11520374. DOI: 10.1186/s13052-024-01776-w.


Gut-derived metabolite 3-methylxanthine enhances cisplatin-induced apoptosis via dopamine receptor D1 in a mouse model of ovarian cancer.

Mai Z, Han Y, Liang D, Mai F, Zheng H, Li P mSystems. 2024; 9(7):e0130123.

PMID: 38899930 PMC: 11264688. DOI: 10.1128/msystems.01301-23.


The Cytotoxic Effects of Nyaope, a Heroin-based Street Drug, in Neuroblastoma Cells.

Daniels W, Sekhotha M, Morgan N, Manilall A IBRO Neurosci Rep. 2024; 16:280-290.

PMID: 38374957 PMC: 10875117. DOI: 10.1016/j.ibneur.2024.01.014.


50 Hz Magnetic Field Exposure Inhibited Spontaneous Movement of Zebrafish Larvae through ROS-Mediated syn2a Expression.

Guo Y, Fu Y, Sun W Int J Mol Sci. 2023; 24(8).

PMID: 37108734 PMC: 10144198. DOI: 10.3390/ijms24087576.


Caffeine increases performance and leads to a cardioprotective effect during intense exercise in cyclists.

Sampaio-Jorge F, Morales A, Pereira R, Barth T, Goncalves Ribeiro B Sci Rep. 2021; 11(1):24327.

PMID: 34934054 PMC: 8692308. DOI: 10.1038/s41598-021-03158-2.


References
1.
Agnati L, Ferre S, Lluis C, Franco R, Fuxe K . Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev. 2003; 55(3):509-50. DOI: 10.1124/pr.55.3.2. View

2.
Fredholm B, Svenningsson P . Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities. Neurology. 2003; 61(11 Suppl 6):S5-9. DOI: 10.1212/01.wnl.0000095204.89871.ff. View

3.
Wolf M, Mangiavacchi S, Sun X . Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann N Y Acad Sci. 2003; 1003:241-9. DOI: 10.1196/annals.1300.015. View

4.
Hernandez-Lopez S, Bargas J, Surmeier D, Reyes A, Galarraga E . D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance. J Neurosci. 1997; 17(9):3334-42. PMC: 6573659. View

5.
Harvey J, Lacey M . A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J Neurosci. 1997; 17(14):5271-80. PMC: 6793812. View